CRSP
Price
$51.60
Change
-$1.45 (-2.73%)
Updated
Aug 29, 03:54 PM (EDT)
Capitalization
4.82B
61 days until earnings call
RXRX
Price
$4.68
Change
-$0.18 (-3.70%)
Updated
Aug 29, 04:17 PM (EDT)
Capitalization
2.11B
68 days until earnings call
Interact to see
Advertisement

CRSP vs RXRX

Header iconCRSP vs RXRX Comparison
Open Charts CRSP vs RXRXBanner chart's image
CRISPR Therapeutics AG
Price$51.60
Change-$1.45 (-2.73%)
Volume$334
Capitalization4.82B
Recursion Pharmaceuticals
Price$4.68
Change-$0.18 (-3.70%)
Volume$3.8K
Capitalization2.11B
CRSP vs RXRX Comparison Chart in %
Loading...
CRSP
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
RXRX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
CRSP vs. RXRX commentary
Aug 29, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is CRSP is a Hold and RXRX is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Aug 29, 2025
Stock price -- (CRSP: $53.05 vs. RXRX: $4.86)
Brand notoriety: CRSP and RXRX are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: CRSP: 45% vs. RXRX: 50%
Market capitalization -- CRSP: $4.82B vs. RXRX: $2.11B
CRSP [@Biotechnology] is valued at $4.82B. RXRX’s [@Biotechnology] market capitalization is $2.11B. The market cap for tickers in the [@Biotechnology] industry ranges from $100.52B to $0. The average market capitalization across the [@Biotechnology] industry is $1.84B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

CRSP’s FA Score shows that 0 FA rating(s) are green whileRXRX’s FA Score has 1 green FA rating(s).

  • CRSP’s FA Score: 0 green, 5 red.
  • RXRX’s FA Score: 1 green, 4 red.
According to our system of comparison, both CRSP and RXRX are a bad buy in the long-term.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

CRSP’s TA Score shows that 2 TA indicator(s) are bullish while RXRX’s TA Score has 4 bullish TA indicator(s).

  • CRSP’s TA Score: 2 bullish, 7 bearish.
  • RXRX’s TA Score: 4 bullish, 6 bearish.
According to our system of comparison, RXRX is a better buy in the short-term than CRSP.

Price Growth

CRSP (@Biotechnology) experienced а +0.44% price change this week, while RXRX (@Biotechnology) price change was +1.78% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was -1.14%. For the same industry, the average monthly price growth was +15.09%, and the average quarterly price growth was +29.14%.

Reported Earning Dates

CRSP is expected to report earnings on Oct 29, 2025.

RXRX is expected to report earnings on Nov 05, 2025.

Industries' Descriptions

@Biotechnology (-1.14% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
CRSP($4.83B) has a higher market cap than RXRX($2.11B). CRSP YTD gains are higher at: 34.782 vs. RXRX (-28.033). CRSP has higher annual earnings (EBITDA): -533.5M vs. RXRX (-583.64M). CRSP has more cash in the bank: 1.72B vs. RXRX (525M). RXRX has less debt than CRSP: RXRX (88.1M) vs CRSP (215M). RXRX has higher revenues than CRSP: RXRX (64.5M) vs CRSP (35M).
CRSPRXRXCRSP / RXRX
Capitalization4.83B2.11B228%
EBITDA-533.5M-583.64M91%
Gain YTD34.782-28.033-124%
P/E RatioN/AN/A-
Revenue35M64.5M54%
Total Cash1.72B525M328%
Total Debt215M88.1M244%
FUNDAMENTALS RATINGS
CRSP: Fundamental Ratings
CRSP
OUTLOOK RATING
1..100
64
VALUATION
overvalued / fair valued / undervalued
1..100
64
Fair valued
PROFIT vs RISK RATING
1..100
100
SMR RATING
1..100
100
PRICE GROWTH RATING
1..100
48
P/E GROWTH RATING
1..100
100
SEASONALITY SCORE
1..100
50

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
CRSPRXRX
RSI
ODDS (%)
Bearish Trend 4 days ago
88%
Bullish Trend 2 days ago
90%
Stochastic
ODDS (%)
Bullish Trend 2 days ago
73%
Bullish Trend 2 days ago
77%
Momentum
ODDS (%)
Bearish Trend 2 days ago
84%
Bearish Trend 2 days ago
90%
MACD
ODDS (%)
Bearish Trend 2 days ago
80%
Bearish Trend 2 days ago
90%
TrendWeek
ODDS (%)
Bullish Trend 2 days ago
77%
Bullish Trend 2 days ago
82%
TrendMonth
ODDS (%)
Bearish Trend 2 days ago
85%
Bearish Trend 2 days ago
86%
Advances
ODDS (%)
Bullish Trend 15 days ago
80%
Bullish Trend 8 days ago
85%
Declines
ODDS (%)
Bearish Trend 2 days ago
83%
Bearish Trend 10 days ago
89%
BollingerBands
ODDS (%)
N/A
Bullish Trend 2 days ago
85%
Aroon
ODDS (%)
Bearish Trend 2 days ago
84%
Bearish Trend 2 days ago
86%
View a ticker or compare two or three
Interact to see
Advertisement
CRSP
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
RXRX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
BLDIX9.690.01
+0.10%
BlackRock Managed Income Institutional
FFANX13.89N/A
N/A
Fidelity Asset Manager 40%
QRVLX32.86N/A
N/A
FPA Queens Road Value
PGOEX83.47N/A
N/A
Putnam Large Cap Growth R6
LGCWX19.72N/A
N/A
Lord Abbett Global Equity R6

CRSP and

Correlation & Price change

A.I.dvisor indicates that over the last year, CRSP has been closely correlated with RXRX. These tickers have moved in lockstep 69% of the time. This A.I.-generated data suggests there is a high statistical probability that if CRSP jumps, then RXRX could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To CRSP
1D Price
Change %
CRSP100%
-0.90%
RXRX - CRSP
69%
Closely correlated
-0.51%
BEAM - CRSP
67%
Closely correlated
-0.06%
NTLA - CRSP
63%
Loosely correlated
+1.58%
CRBU - CRSP
60%
Loosely correlated
-2.02%
PRME - CRSP
58%
Loosely correlated
+0.29%
More

RXRX and

Correlation & Price change

A.I.dvisor indicates that over the last year, RXRX has been closely correlated with CRSP. These tickers have moved in lockstep 69% of the time. This A.I.-generated data suggests there is a high statistical probability that if RXRX jumps, then CRSP could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To RXRX
1D Price
Change %
RXRX100%
-0.51%
CRSP - RXRX
69%
Closely correlated
-0.90%
BEAM - RXRX
64%
Loosely correlated
-0.06%
ABSI - RXRX
62%
Loosely correlated
-3.14%
ABCL - RXRX
58%
Loosely correlated
-1.15%
NTLA - RXRX
56%
Loosely correlated
+1.58%
More